Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    LY2886721
Show Display Options
Download search resultsDownload the search results for:
LY2886721 (7 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Disposition of 14C-LY2886721 Following Oral Administration in Healthy Human Subjects
Condition: Healthy Subjects
Intervention: Drug: LY2886721
2 Completed A Study of Two Dosage Forms of LY2886721 in Healthy Participants
Condition: Healthy Volunteers
Interventions: Drug: LY2886721 Capsule;   Drug: LY2886721 ODT
3 Completed A Safety Study of LY2886721 Multiple Doses in Healthy Subjects
Condition: Alzheimer's Disease
Interventions: Drug: LY2886721;   Drug: Placebo
4 Completed A Study of LY2886721 in Healthy Participants
Condition: Healthy Volunteers
Interventions: Drug: LY2886721;   Drug: Placebo
5 Completed A Safety Study of LY2886721 Single Doses in Healthy Subjects
Condition: Alzheimer's Disease
Interventions: Drug: LY2886721;   Drug: Placebo
6 Completed A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
Conditions: Alzheimer Disease;   Healthy Volunteers
Interventions: Drug: LY2886721;   Drug: Placebo
7 Terminated Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY2886721;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.